In-vitro Diagnostics Market Size & Share, by Product Type (Instruments, Reagents & Consumables); Test (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology); Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 1354
Published Date: Feb 06, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the In-Vitro Diagnostics Landscape

Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Roche Diagnostics
DiaSorin S. p. A.
Johnson & Johnson corporation
Becton, Dickinson and Company
Siemens Healthineers
Danaher Corporations
Bio-Rad Laboratories
Thermo Fisher Scientific
Pfizer Inc.

Browse Key Market Insights with Data Illustration:

In-vitro Diagnostics Market Size & Share, Growth Trends 2033

In the News

Abbott Laboratories received US FDA clearance for the Freestyle libre 2 iOS application for use with compatible iPhones.
Roche Diagnostics launched the Cobas pulse system, a blood glucose management solution with mobile digital health capabilities to improve patient care.

Frequently Asked Questions (FAQ)

Increasing awareness towards point-of-care testing from centralized testing, and increase in chronic and infectious diseases are anticipated to be the major factors driving the growth of the in-vitro diagnostics market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023-2033.

High cost of diagnostic services and machinery maintenance and unfavorable scenario are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Abbott, Roche Diagnostics, DiaSorin, Johnson & Johnson, Becton, Dickinson and Company, Siemens Healthineers, Danaher Corporations, Bio-Rad Laboratories, and Thermo Fisher Scientific.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, test type, application, end-user, and by region.

The oncology is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the In-Vitro Diagnostics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the In-vitro diagnostics market?

What would be the CAGR of In-vitro diagnostics market over the forecast period?

What are the challenges affecting the In-vitro diagnostics market growth?

Which region will provide more business opportunities for growth of In-vitro diagnostics market in future?

Who are the major players dominating the In-vitro diagnostics market?

How are the company profiles selected?

What are the segments in the in-vitro diagnostics market?

Which segment captures the largest market size in application in the in-vitro diagnostics market?